Loading...
NPI 1932184322 · Dublin, OH · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Laboratory Corporation Of America Holdings is a clinical medical laboratory provider located in Dublin, Ohio. This profile covers 528 Medicare and 566 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Laboratory Corporation Of America Holdings |
| Address | 6370 Wilcox Rd |
| City | Dublin |
| State | OH |
| ZIP | 43016 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | December 8, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $617M |
| Medicare | $56.9M |
This provider’s billing profile is heavily weighted toward Medicaid in scale: reported Medicaid lifetime revenue is $617M compared with Medicare lifetime revenue of $56.9M, indicating the provider operates at a much larger footprint in the state Medicaid market than in Medicare. Both payers show extensive test volume, but Medicaid drives the majority of lifetime dollars on file for this NPI.
Clinical-service mix is firmly diagnostic laboratory–centric with very high volumes of routine chemistry and endocrine tests: Medicare top codes include 80053, 80061, and 84443 and Medicaid mirrors that pattern with large volumes for 80053, 84443, 82306 and 80061. The presence of high-claim specimen collection codes such as 36415 (551.2K claims on Medicare) and high-volume CBC 85025 (414.1K claims on Medicare; 3.5M claims on Medicaid) supports a centralized, high-throughput phlebotomy and specimen-processing operation.
Revenue concentration is meaningful but not hyper-concentrated: the precomputed top-3 Medicare codes account for 34.6% of this provider’s total Medicare revenue, while the precomputed top-3 Medicaid codes account for 31.4% of total Medicaid revenue. These shares show that a relatively small set of high-volume tests drives roughly one-third of revenue for each payer, leaving substantial revenue coming from the long tail of additional assays and panels.
National competitive standing on Medicare is dominant for routine lab testing: multiple Medicare codes such as 80053 (ranks #7 of 26416; 100th percentile; extreme outlier), 80061 (ranks #7; 100th percentile; extreme outlier), 84443 (ranks #7; 100th percentile; extreme outlier), and 36415 (ranks #9; 100th percentile; extreme outlier) are characterized as extreme outliers versus national peers, signaling volumes far above typical national providers for those tests. At the same time, certain specialized tests like 81490 (ranks #4 of 20; 84th percentile; typical, unremarkable volume) do not show the same national dominance, indicating market leadership is concentrated in high-volume routine assays.
State-level competitive standing in Medicaid is pronounced: the provider ranks #1 in-state for numerous high-revenue Medicaid codes including U0003 ($62.6M revenue; 14.4% of Medicaid revenue), 87389 ($44.7M; 10.3%), 80050 ($28.7M; 6.6%), and many others — most flagged as 100th percentile; extreme outlier. This pattern identifies the entity as a statewide leader for COVID PCR, HIV screening, general health panels, vitamin D testing, lipid panels and multiple high-volume NAATs and immunoassays.
Operational throughput and service breadth are evident from the claim counts across both payers: very large claim volumes such as Medicare 80053 (518.8K claims) and Medicaid 80053 (3.8M claims), Medicaid 84443 (2.4M claims), and Medicaid 82306 (1.8M claims) indicate a high-capacity central lab that processes both routine screening and condition-specific testing at scale. High claim counts for sexually transmitted infection NAATs (Medicaid 87491 520.8K claims; 87591 518.9K claims) and for COVID testing (Medicaid U0003 921.2K claims) further demonstrate broad infectious-disease testing capabilities and public-health volume.
The provider’s service mix includes both high-throughput routine assays and more complex molecular/genetic services: Medicaid shows substantial revenue for molecular/genomic panels such as 81420 ($21M; 4.8% of Medicaid revenue) and 81220 ($7.3M; 1.7%), while Medicare lists advanced immunoassay/algorithmic tests such as 81490 ($1M; 2.4% of Medicare revenue). This combination implies a diversified lab business that captures routine diagnostic flow while also participating in higher-reimbursement specialized testing.
This NPI has long tenure in the dataset, enumerated on 2005-12-08 (~21 years ago), which aligns with the scale and systematized operations shown by the volume and breadth of codes reported across both payers. The longevity plus repeated top-state and top-national ranks suggests an established laboratory network with sustained contracts and referral relationships that produce the reported high volumes.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
528 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 518,750 | $10 | $5.2M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 360,870 | $10 | $4.7M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 285,860 | $20 | $4.6M |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 551,200 | $10 | $4.4M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 145,810 | $30 | $4.2M |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 414,090 | $10 | $3.3M |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 243,360 | $10 | $2.4M |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 96,400 | $20 | $1.4M |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 28,700 | $40 | $1.1M |
| 81490 | The lab analyst performs the technical lab tests for 12 serum biomarker immunoassays, and carries out an algorithmic analysis using patient data and the lab test results to report a patient disease… | 1,230 | $820 | $1M |
Showing 1–10 of 528
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 528 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
528 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81490 | 1 | 10 | 630 | $820 | $517.4K |
| P9603 | 6 | 10 | 8,540 | $1 | $457.4K |
| 83698 | 2 | 10 | 80 | $50 | $302.7K |
| 82542 | 2 | 10 | 100 | $20 | $160K |
| 87798 | 5 | 10 | 90 | $30 | $129.1K |
| 83704 | 2 | 10 | 80 | $30 | $76.9K |
| 86037 | 1 | 10 | 6,340 | $10 | $74.8K |
| 83521 | 1 | 10 | 340 | $20 | $72.5K |
| U0003 | 1 | 10 | 140 | $70 | $68.2K |
| 82777 | 2 | 10 | 1,260 | $40 | $54.4K |
Showing 1–10 of 528
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
566 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 921,200 | $70 | $62.6M |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 1,241,900 | $40 | $44.7M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 957,290 | $30 | $28.7M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 3,831,700 | $10 | $26.8M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 2,431,040 | $10 | $26.7M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 1,790,270 | $10 | $25.1M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 3,464,440 | $10 | $24.3M |
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 62,810 | $330 | $21M |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 3,528,190 | $10 | $17.6M |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 2,795,000 | $10 | $16.8M |
Showing 1–10 of 566
How this provider's Medicaid billing volume and revenue compare to other Ohio providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Ohio median
566 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 1 | 10 | 510 | $320 | $4M |
| 81381 | The lab analyst performs the technical lab test for high resolution assessment of human leukocyte antigen genes, called HLA, for one Class I allele or allele group of interest, typically one that is… | 2 | 10 | 1,140 | $40 | $3.4M |
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 7 | 10 | 760 | $50 | $2M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 1 | 140 | 1,130 | $90 | $1.1M |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 27 | 80 | 910 | $110 | $884.9K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3 | 50 | 310 | $110 | $817.2K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 1 | 50 | 220 | $30 | $675.9K |
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 1 | 20 | 480 | $50 | $671.8K |
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 1 | 20 | 170 | $210 | $485.4K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 3 | 340 | 2,260 | $30 | $398.2K |
Showing 1–10 of 566
Other providers in the same ZIP code as Laboratory Corporation Of America Holdings, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.